MEDIMMUNE INC /DE
10-Q, EX-27, 2000-08-10
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: MEDIMMUNE INC /DE, 10-Q, EX-10.120, 2000-08-10
Next: JONES APPAREL GROUP INC, 10-Q, 2000-08-10



<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
This schedule contains summary financial  information  extracted from MedImmune,
Inc.'s  quarterly report on Form 10-Q for the six months ended June 30, 2000 and
is qualified in its entirety by reference to such filing.
</LEGEND>

<CIK>                                          0000873591
<NAME>                                         MEDIMMUNE, INC.

<MULTIPLIER>                                   1,000


<S>                             <C>
<PERIOD-TYPE>                                  6-MOS
<FISCAL-YEAR-END>                              Dec-31-2000
<PERIOD-END>                                   Jun-30-2000
<CASH>                                         118,159
<SECURITIES>                                   330,289
<RECEIVABLES>                                      840
<ALLOWANCES>                                         0
<INVENTORY>                                     35,472
<CURRENT-ASSETS>                               488,749
<PP&E>                                          89,101
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 801,161
<CURRENT-LIABILITIES>                           61,368
<BONDS>                                         10,012
                                0
                                          0
<COMMON>                                         2,098
<OTHER-SE>                                     725,701
<TOTAL-LIABILITY-AND-EQUITY>                   801,161
<SALES>                                        221,163
<TOTAL-REVENUES>                               227,844
<CGS>                                           57,042
<TOTAL-COSTS>                                  167,901
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 243
<INCOME-PRETAX>                                 72,817
<INCOME-TAX>                                    23,665
<INCOME-CONTINUING>                             49,152
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    49,152
<EPS-BASIC>                                       0.24
<EPS-DILUTED>                                     0.22


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission